Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Henry Schein : Greater Control and Visibility for Dental Procedures with Zyris' Dental Isolation Systems, Exclusively Distributed by Henry Schein

09/03/2020 | 08:10am EST

Company to Offer Zyris’ Complete Dental Isolation System Featuring Isolite® 3, Isovac® 2, Isodry®, and Full Line of Mouthpieces

Henry Schein, Inc. (Nasdaq: HSIC) today announced that it has entered into an agreement with Zyris, Inc. (formerly, Isolite Systems) to be the exclusive distributor of their complete dental isolation system. The company is offering Zyris’ complete dental isolation system and its full line of mouthpieces to help dental practitioners, dental assistants, and hygienists have greater control and visibility for dental procedures that require patients’ teeth to be isolated, and repaired dry, such as as laser surgery, crown preparations, restorations, or extractions.

Minimizing bacteria to the mouth, this suite of solutions can enhance infection control protocols and aerosol management, helping practices provide a safer, and more efficient patient experience. The dental isolation system features hands-free, high-volume evacuator (HVE) devices, and mouthpieces – all manufactured in the United States – that connect to a dental chair’s HVE line, giving dental professionals continuous suction throughout the entire procedure; retraction of the patient’s tongue and cheek to provide dentists with more working room; and airway protection from the water, blood, saliva, and debris associated with dental surgery.

“As we continue to help our customers reopen their practices, it is essential that we offer solutions that enhance infection prevention protocols,” said AJ Caffentzis, President, U.S. Dental Distribution. “Thanks to our valued partner, Zyris, and its dental isolation system, our customers can rely on us to help them deliver a safer and more comfortable experience for their patients.”

Designed to improve safety, comfort, and convenience for patients, as well as enhance practice efficiencies, Zyris’ dental isolation system, as exclusively distributed by Henry Schein, includes:

  • Isolite® 3 – The isolation device provides continuous hands-free suction to evacuate debris, helping to help mitigate negative variables that can impact treatment, including moisture, contamination, soft tissue interference, low visibility, and restricted access. To help improve visibility and access into a patient’s oral cavity, the tool features an integrated, long-lasting LED light (white and non-curing amber) with three levels of brightness. Illumination from this tool can provide enhanced visibility when placing light-sensitive materials, including resins, composites, and adhesives.
  • Isovac® 2 – This tool is an adapter that can help improve mobility in the practice workflow, as it can easily be relocated to any operatory in a dental practice, and connected to an existing HVE line, ideal for dental teams who need additional support to maximize productivity. The Isovac 2 control head can be disassembled in seconds for quick and easy cleaning. Further contributing to increased efficiencies, the Isovac 2 is sold as a three-pack, which allows for one Isovac 2 to be in use, one Isovac 2 to be ready for the next patient, and one Isovac 2 to be cleaned and autoclaved after each patient.
  • Isodry® – Connected directly into the dental chair’s HVE line and featuring an integrated vacuum hose, the strong, ultra-lightweight Isodry control head assembly is constructed of titanium and weighs only 2.5 ounces. The tool comes with six vacuum pipes that connect Zyris’ mouthpieces to the Isodry control head, giving dental teams the ability to treat six patients before the vacuum pipes need to be autoclaved.
  • Mouthpieces – Zyris’ patented, single-use mouthpieces, which can be attached to each of the three devices, retract the patient’s tongue and cheek, protect the patient’s airway, and keep the mouth gently propped open. Continuous two-channel adjustable suctioning facilitates the reduction of aerosols intraorally during dental procedures. Available in six sizes, the mouthpieces are designed to comfortably fit a broad range of patients from pediatric to geriatric, and each mouthpiece is constructed of soft polymeric material to help ensure their comfort.

“We are thrilled to partner with Henry Schein, whose extensive dental customer base can create a positive, minimally invasive dental experience for patients with our award-winning, easy-to-use dental isolation products,” said Sandra Hirsch, President and CEO, Zyris. “Together, we are committed to promoting better oral health through highly effective and technologically advanced solutions; helping more clinicians achieve optimal visibility, moisture control, improved efficiency, and consistent results.”

For more information, please visit www.henryscheindental.com/isolite.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

© Business Wire 2020
All news about HENRY SCHEIN, INC.
11/25HENRY SCHEIN : Announces Virtual Presence at Greater New York Dental Meeting Foc..
11/17HENRY SCHEIN : Announces Participation in Upcoming Virtual Conferences in Decemb..
11/02HENRY SCHEIN : Vertical Market Data
11/02HENRY SCHEIN : Reconciliation of GAAP and Non-GAAP Measures
11/02HENRY SCHEIN : 3Q Earnings Snapshot
10/28HENRY SCHEIN, INC. : quaterly earnings release
10/28HENRY SCHEIN : Announces Distribution Agreement with Carrizo Dental to Provide O..
10/27HENRY SCHEIN : Announces Participation in Upcoming Virtual Conferences in Novemb..
10/26HENRY SCHEIN : TDSC.com, Powered by Henry Schein Is Now Live
More news
Financials (USD)
Sales 2020 9 823 M - -
Net income 2020 401 M - -
Net Debt 2020 412 M - -
P/E ratio 2020 22,6x
Yield 2020 -
Capitalization 9 182 M 9 182 M -
EV / Sales 2020 0,98x
EV / Sales 2021 0,86x
Nbr of Employees 19 000
Free-Float 98,6%
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 18
Average target price 70,20 $
Last Close Price 64,31 $
Spread / Highest target 39,9%
Spread / Average Target 9,16%
Spread / Lowest Target -8,26%
EPS Revisions
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Philip A. Laskaway Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.-4.56%9 092
OWENS & MINOR, INC.381.82%1 831
TOKAI CORP.-26.13%729